Showing results (191-200 of 198) with videos related to
Sort By:
Pageof 20
You have reached the last page of results.This site can display upto 198 results.
Blood|November 20, 2010
CD8+ T-cell expansion and maintenance after recombinant adenovirus immunization rely upon cooperation between hematopoietic and nonhematopoietic antigen-presenting cellsJennifer D Bassett, Teng Chih Yang, Dannie Bernard, et al.Plos Pathogens|May 6, 2016
Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayVarun C Anipindi, Puja Bagri, Kristy Roth, et al.ERJ Open Research|June 10, 2025
AeroVax: study protocol for a randomised, double-blind, placebo-controlled, phase 2 trial to evaluate safety and immunogenicity of a next-generation COVID-19 vaccine delivered by inhaled aerosol to humansAdam S Komorowski, Lawrence Mbuagbaw, Mangalakumari Jeyanathan, et al.Plos Pathogens|June 9, 2016
Correction: Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent PathwayVarun C Anipindi, Puja Bagri, Kristy Roth, et al.JCI Insight|January 6, 2022
Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humansMangalakumari Jeyanathan, Dominik K Fritz, Sam Afkhami, et al.Journal of Synchrotron Radiation|May 2, 2015
The Matter in Extreme Conditions instrument at the Linac Coherent Light SourceBob Nagler, Brice Arnold, Gary Bouchard, et al.Nature Communications|July 2, 2025
Induction of lung mucosal immunity by a next-generation inhaled aerosol COVID-19 vaccine: an open-label, multi-arm phase 1 clinical trialMangalakumari Jeyanathan, Sam Afkhami, Michael R D'Agostino, et al.Cell|February 18, 2022
Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2Sam Afkhami, Michael R D'Agostino, Ali Zhang, et al.Pageof 20